What follow-up protocols should I implement for patients treated for Bowen's disease?

Follow-up protocols for patients treated for Bowen's disease should include regular clinical skin examinations to monitor for recurrence or new lesions, as Bowen's disease is a form of squamous cell carcinoma in situ with potential for progression.

Although the provided UK guidelines focus primarily on melanoma and thyroid cancer follow-up, general dermatological practice and NICE guidance on skin cancer management recommend that patients treated for Bowen's disease receive periodic skin checks by healthcare professionals skilled in skin cancer assessment, including dermoscopy where available.

Patients should be advised on self-examination and sun protection measures to reduce risk of further skin lesions.

There is no specific routine imaging or laboratory follow-up recommended for Bowen's disease unless invasive squamous cell carcinoma is suspected or confirmed.

Referral back to specialist dermatology or skin cancer services should be available if new suspicious lesions develop.

In summary, follow-up is primarily clinical and patient education-focused, with personalised follow-up intervals based on individual risk factors and clinical judgement.

Note: The detailed UK NICE guidelines provided do not specifically address Bowen's disease follow-up protocols but focus on melanoma and thyroid cancer management ¹,².